TSS
INMB icon

Two Sigma Securities’s INmune Bio INMB Stock Holding History

Two Sigma Securities’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.4K Sell
14,530
-10,833
-43% -$15.4K ﹤0.01% 1400
2025
Q4 		$39.6K Buy
+25,363
New +$45.3K 0.01% 1104

Other funds holding INMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Two Sigma Securities's INMB Position: Q1 2026 in Review

Two Sigma Securities reduced its INmune Bio (INMB) stake by 43% in Q1 2026, selling an estimated $15.4K and leaving 14,530 shares worth $16.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1400.

Two Sigma Securities first reported a position in INMB in Q4 2025 and has held it in 2 quarters since. The position peaked at $39.6K in Q4 2025. 82 funds tracked by Wall St. Rank hold INMB as of Q1 2026.

  • Two Sigma Securities held 14,530 shares of INmune Bio worth $16.4K as of Q1 2026.
  • Two Sigma Securities sold 10,833 INmune Bio shares in Q1 2026, an estimated $15.4K.
  • INmune Bio made up ﹤0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1400 holding.
  • Two Sigma Securities first reported a position in INmune Bio in Q4 2025 and has held it in 2 quarters since.
  • Two Sigma Securities's INmune Bio position peaked at $39.6K in Q4 2025.
  • 82 funds tracked by Wall St. Rank held INmune Bio as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.